IQVIA's investments in these technologies could yield significant returns. The company's ability to integrate AI across its service offerings has the potential to enhance the efficiency and ...

The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...

IQVIA conducted a thorough ... Integrating the patient journey Failures in patient engagement and retention can delay or stop a clinical trial. DCT studies are proving to be helpful with this ...

and accelerate R&D efforts that are for patients and driven by them. Stewart Rosen, MD, vice president, medical, clinical trial educators, IQVIA Bringing more than 35 years of industry experience ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

Five mid-career journalists have been selected as the inaugural Public Health Reporting Fellowship cohort coordinated by the National Press Club Journalism Institute with backing from the Common ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

IQVIA: BIOSIMILAR VOID AWAITS — A new report from health data firm IQVIA released Monday found that of the 118 biologics with expiring patient ... green light to a clinical trial examining ...

This database includes 10 million patient records and 20 million high-resolution slide images. Such a comprehensive ... Human digital twins can be used in clinical trials, medical training ...

The chipmaker said its technology will be used to develop solutions such as AI agents that can speed up clinical trials, and physical AI robots for surgery and patient monitoring. “AI offers an ...

Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...